Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
5.83
-0.12 (-2.02%)
At close: Jan 30, 2026, 4:00 PM EST
5.94
+0.11 (1.89%)
After-hours: Jan 30, 2026, 7:30 PM EST
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $307.21 million as of January 30, 2026. Its market cap has increased by 452.89% in one year.
Market Cap
307.21M
Enterprise Value
292.37M
1-Year Change
452.89%
Ranking
Category
Stock Price
$5.83
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $307.21M, an increase of 367.29%. That is a compound annual growth rate of 45.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 307.21M | 11.47% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 328.76M |
| Cybin | 326.87M |
| Foghorn Therapeutics | 325.71M |
| Candel Therapeutics | 324.45M |
| Atea Pharmaceuticals | 319.54M |
| Aldeyra Therapeutics | 318.26M |
| Puma Biotechnology | 317.97M |
| XOMA Royalty | 306.92M |